封面
市場調查報告書
商品編碼
1714388

活體組織切片設備市場-全球產業規模、佔有率、趨勢、機會和預測,按產品類型、疾病類型、解剖結構、引導技術、地區和競爭細分,2020 年至 2030 年

Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Disease Type, By Anatomy, By Guidance Technique, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球切片設備市場價值為 61.7 億美元,預計到 2030 年將達到 88.4 億美元,預測期內複合年成長率為 6.18%。該市場是醫療保健行業的一個重要領域,其發展受到癌症發病率不斷上升和對精確診斷方法的需求的推動。活體組織切片設備透過收集組織樣本進行分析,對於早期識別疾病(尤其是癌症)至關重要。技術創新、人口老化以及對影像導引和液體活體組織切片等微創手術的日益青睞進一步推動了這一需求。機器人和人工智慧的進步也提高了診斷的準確性和程序效率。

市場概覽
預測期 2026-2030
2024年市場規模 61.7億美元
2030年市場規模 88.4億美元
2025-2030 年複合年成長率 6.18%
成長最快的領域 液體活體組織切片
最大的市場 北美洲

關鍵市場促進因素

癌症發生率上升

主要市場挑戰

切片費用高昂

主要市場趨勢

微創技術的發展

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:全球切片設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型(組織切片、液體切片)
    • 依疾病類型(癌症、感染、自體免疫疾病、非癌症適應症、其他)
    • 依解剖學分類(乳房、肺、骨、肝、子宮/子宮頸/卵巢、腹部、前列腺、心臟、皮膚、其他)
    • 依引導技術(X 光引導活體組織切片、超音波引導活體組織切片、MRI 引導活體組織切片、CT 引導活體組織切片)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖
    • 依產品類型
    • 依疾病類型
    • 按解剖學
    • 透過引導技術
    • 按地區

第5章:亞太地區切片設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型
    • 依疾病類型
    • 按解剖學
    • 透過引導技術
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章:歐洲切片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章:北美切片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章:南美洲切片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第9章:中東和非洲活體組織切片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章:市場動態

  • 驅動程式
  • 挑戰

第 11 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 12 章:全球切片設備市場:SWOT 分析

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical Inc.
  • Conmed Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Inrad, Inc.

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16264

The Global Biopsy Devices Market was valued at USD 6.17 billion in 2024 and is anticipated to reach USD 8.84 billion by 2030, registering a CAGR of 6.18% during the forecast period. This market is a vital segment of the healthcare industry, driven by the growing incidence of cancer and the need for precise diagnostic methods. Biopsy devices are essential in identifying diseases at early stages, particularly cancer, by collecting tissue samples for analysis. The demand is further fueled by technological innovations, an aging population, and the increasing preference for minimally invasive procedures like image-guided and liquid biopsies. Advancements in robotics and AI are also enhancing diagnostic accuracy and procedural efficiency.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.17 Billion
Market Size 2030USD 8.84 Billion
CAGR 2025-20306.18%
Fastest Growing SegmentLiquid Biopsy
Largest MarketNorth America

Key Market Drivers

Rising Cancer Prevalence

The escalating global incidence of cancer significantly propels the demand for biopsy devices. As cancer becomes more widespread, the need for accurate diagnostic methods grows more urgent. Biopsy procedures are critical in confirming cancer diagnoses, determining types and stages, and guiding effective treatment plans. According to the Union for International Cancer Control (UICC), the number of new cancer cases is projected to exceed 35 million by 2050, marking a 77% increase from 2022. This alarming rise underscores the importance of biopsy tools in healthcare systems, as early and reliable diagnosis is central to improving patient outcomes and expanding access to appropriate therapies.

Key Market Challenges

High Cost of Biopsy Procedures

A significant challenge for the global biopsy devices market is the high cost associated with biopsy procedures. These costs include not only the price of specialized equipment but also expenses related to diagnostics, professional services, and post-procedure care. For patients, especially those with limited financial means or inadequate insurance coverage, out-of-pocket expenses can deter timely diagnosis. Even for healthcare providers, the acquisition and maintenance of advanced biopsy equipment, workforce training, and regulatory compliance impose substantial financial burdens. These economic constraints limit accessibility and slow adoption, particularly in developing regions, posing a barrier to market expansion.

Key Market Trends

Growth of Minimally Invasive Techniques

The increasing adoption of minimally invasive biopsy techniques is a transformative trend in the global biopsy devices market. Unlike traditional surgical biopsies, these methods-such as fine-needle aspiration, core needle biopsies, and image-guided procedures-offer less invasive alternatives with reduced discomfort and faster recovery. These patient-friendly approaches not only improve diagnostic efficiency but also increase the appeal of biopsy procedures, driving demand. Minimally invasive methods enable sampling from hard-to-reach areas and are associated with lower complication rates. Their growing acceptance among both patients and providers is accelerating market growth and reshaping diagnostic practices across healthcare systems.

Key Market Players

  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical Inc.
  • Conmed Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Inrad, Inc

Report Scope:

In this report, the Global Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopsy Devices Market, By Product Type:

  • Tissue Biopsy
  • Liquid Biopsy

Biopsy Devices Market, By Disease Type:

  • Cancer
  • Infections
  • Autoimmune Disorders
  • Non-Cancerous Indications
  • Others

Biopsy Devices Market, By Anatomy:

  • Breast
  • Lung
  • Bone
  • Liver
  • Uterus/Cervix/Ovary
  • Abdomen
  • Prostate
  • Cardiac
  • Skin
  • Others

Biopsy Devices Market, By Guidance Technique:

  • X-Ray-Guided Biopsy
  • Ultrasound-Guided Biopsy
  • MRI-Guided Biopsy
  • CT-Guided Biopsy

Biopsy Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biopsy Devices Market.

Available Customizations:

Global Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Biopsy Devices Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product Type (Tissue Biopsy, Liquid Biopsy)
    • 4.2.2. By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others)
    • 4.2.3. By Anatomy (Breast, Lung, Bone, Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, Others)
    • 4.2.4. By Guidance Technique (X-Ray-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy)
    • 4.2.5. By Region
    • 4.2.6. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Product Type
    • 4.3.2. By Disease Type
    • 4.3.3. By Anatomy
    • 4.3.4. By Guidance Technique
    • 4.3.5. By Region

5. Asia Pacific Biopsy Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Disease Type
    • 5.2.3. By Anatomy
    • 5.2.4. By Guidance Technique
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Biopsy Devices Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product Type
        • 5.3.1.2.2. By Disease Type
        • 5.3.1.2.3. By Anatomy
        • 5.3.1.2.4. By Guidance Technique
    • 5.3.2. India Biopsy Devices Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product Type
        • 5.3.2.2.2. By Disease Type
        • 5.3.2.2.3. By Anatomy
        • 5.3.2.2.4. By Guidance Technique
    • 5.3.3. Australia Biopsy Devices Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product Type
        • 5.3.3.2.2. By Disease Type
        • 5.3.3.2.3. By Anatomy
        • 5.3.3.2.4. By Guidance Technique
    • 5.3.4. Japan Biopsy Devices Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product Type
        • 5.3.4.2.2. By Disease Type
        • 5.3.4.2.3. By Anatomy
        • 5.3.4.2.4. By Guidance Technique
    • 5.3.5. South Korea Biopsy Devices Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product Type
        • 5.3.5.2.2. By Disease Type
        • 5.3.5.2.3. By Anatomy
        • 5.3.5.2.4. By Guidance Technique

6. Europe Biopsy Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Disease Type
    • 6.2.3. By Anatomy
    • 6.2.4. By Guidance Technique
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Biopsy Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Disease Type
        • 6.3.1.2.3. By Anatomy
        • 6.3.1.2.4. By Guidance Technique
    • 6.3.2. Germany Biopsy Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Disease Type
        • 6.3.2.2.3. By Anatomy
        • 6.3.2.2.4. By Guidance Technique
    • 6.3.3. Spain Biopsy Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Disease Type
        • 6.3.3.2.3. By Anatomy
        • 6.3.3.2.4. By Guidance Technique
    • 6.3.4. Italy Biopsy Devices Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Disease Type
        • 6.3.4.2.3. By Anatomy
        • 6.3.4.2.4. By Guidance Technique
    • 6.3.5. United Kingdom Biopsy Devices Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Disease Type
        • 6.3.5.2.3. By Anatomy
        • 6.3.5.2.4. By Guidance Technique

7. North America Biopsy Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Disease Type
    • 7.2.3. By Guidance Technique
    • 7.2.4. By Anatomy
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Biopsy Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Disease Type
        • 7.3.1.2.3. By Anatomy
        • 7.3.1.2.4. By Guidance Technique
    • 7.3.2. Mexico Biopsy Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Disease Type
        • 7.3.2.2.3. By Anatomy
        • 7.3.2.2.4. By Guidance Technique
    • 7.3.3. Canada Biopsy Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Disease Type
        • 7.3.3.2.3. By Anatomy
        • 7.3.3.2.4. By Guidance Technique

8. South America Biopsy Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Disease Type
    • 8.2.3. By Guidance Technique
    • 8.2.4. By Anatomy
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Biopsy Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Disease Type
        • 8.3.1.2.3. By Anatomy
        • 8.3.1.2.4. By Guidance Technique
    • 8.3.2. Argentina Biopsy Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Disease Type
        • 8.3.2.2.3. By Anatomy
        • 8.3.2.2.4. By Guidance Technique
    • 8.3.3. Colombia Biopsy Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Disease Type
        • 8.3.3.2.3. By Anatomy
        • 8.3.3.2.4. By Guidance Technique

9. Middle East and Africa Biopsy Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Disease Type
    • 9.2.3. By Anatomy
    • 9.2.4. By Guidance Technique
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Biopsy Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Disease Type
        • 9.3.1.2.3. By Anatomy
        • 9.3.1.2.4. By Guidance Technique
    • 9.3.2. Saudi Arabia Biopsy Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Disease Type
        • 9.3.2.2.3. By Anatomy
        • 9.3.2.2.4. By Guidance Technique
    • 9.3.3. UAE Biopsy Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Disease Type
        • 9.3.3.2.3. By Anatomy
        • 9.3.3.2.4. By Guidance Technique

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Biopsy Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Argon Medical Devices, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. B. Braun SE
  • 14.3. Becton, Dickinson and Company
  • 14.4. Boston Scientific Corporation
  • 14.5. Cardinal Health, Inc.
  • 14.6. Cook Medical Inc.
  • 14.7. Conmed Corporation
  • 14.8. FUJIFILM Holdings Corporation
  • 14.9. GE HealthCare
  • 14.10. Inrad, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer